DMT vs Ketamine: Mechanisms, Therapy, Legal Status

TL;DR

DMT and ketamine are both being studied for psychiatric use, but practically they are very different:

• Ketamine is a Schedule III dissociative — legal, prescribable, with decades of clinical evidence for depression. Sessions last 1–2 hours. Available today through FDA-approved Spravato and off-label racemic ketamine.
• DMT is a Schedule I psychedelic — illegal outside research and ceremonial contexts. Smoked DMT lasts 15–30 minutes; ayahuasca (oral DMT + MAOI) lasts 4–6 hours; 5-MeO-DMT lasts 30–60 minutes. Clinical trials underway but no approved product yet.
• They act on different receptors — ketamine on NMDA glutamate, DMT on serotonin 5-HT2A.
• Both promote neuroplasticity, but the clinical access gap is large: ketamine is the option you can actually use today.

What is DMT?

DMT (N,N-dimethyltryptamine) is a tryptamine psychedelic that occurs naturally in many plants and in trace amounts in mammalian brain tissue. It is the active compound in ayahuasca, the Amazonian ceremonial brew, when combined with an MAO inhibitor that lets it survive oral digestion.

The major forms relevant to therapy and research:

Form	Route	Onset	Duration
N,N-DMT (smoked / vaped)	Inhalation	Seconds	15–30 min
N,N-DMT (ayahuasca)	Oral with MAOI	30–60 min	4–6 hr
5-MeO-DMT	Inhalation	Seconds	30–60 min

All forms remain Schedule I in the U.S. — meaning the DEA classifies them as having no accepted medical use and high abuse potential, regardless of the research findings. Access outside clinical trials is illegal.

Mechanism: DMT is a potent agonist at the serotonin 5-HT2A receptor, the same receptor implicated in the effects of psilocybin and LSD. Activation produces large-scale changes in cortical activity, vivid visual imagery, and (especially with 5-MeO-DMT) profound shifts in self-perception.

For more on 5-MeO-DMT specifically, see 5-MeO-DMT for depression.

What is ketamine?

Ketamine is a dissociative anesthetic synthesized in 1962 and FDA-approved as a human anesthetic in 1970. It is on the WHO Essential Medicines List.

Psychiatric uses have grown out of two foundational trials:

• Berman et al., 2000 — first showed rapid antidepressant effects of IV ketamine in major depression (Biological Psychiatry)
• Zarate et al., 2006 — demonstrated antidepressant response within 2 hours in treatment-resistant depression (Archives of General Psychiatry)

Two regulatory contexts to understand:

• Spravato (esketamine) is the only FDA-approved ketamine-derived product for treatment-resistant depression. It is administered intranasally in a certified clinic. (FDA approval announcement)
• Racemic ketamine (IV, oral, sublingual) is FDA-approved as an anesthetic but used off-label for depression, anxiety, and PTSD. Off-label use is legal and common — most ketamine therapy in the U.S. uses this form.

Mechanism: at subanesthetic doses, ketamine blocks NMDA glutamate receptors, increases AMPA receptor activation, and triggers BDNF release — driving neuroplastic changes in the prefrontal cortex and hippocampus.

DMT vs ketamine: side-by-side comparison

Feature	Ketamine	DMT
Drug class	Dissociative anesthetic	Classic psychedelic (tryptamine)
Legal status (U.S.)	Schedule III; legal Rx	Schedule I; illegal outside research
FDA approval	Yes (anesthesia + Spravato for TRD)	No
Primary mechanism	NMDA receptor blockade	Serotonin 5-HT2A agonism
Subjective experience	Dissociation, dreamlike inwardness	Intense visions, ego dissolution
Session length	1–2 hours	15 min (smoked) – 6 hr (ayahuasca)
Clinical evidence	Decades; multiple RCTs for depression	Early phase; small trials
Access today	Available via prescription	Clinical trials or ceremonial only
Antidepressant effect onset	Hours	Days (preliminary data)
Risk profile	Dissociation, BP elevation, dependence with abuse	Anxiety / overwhelming experience, vomiting (ayahuasca)

Why are people comparing these two?

Three reasons:

1. Both are "psychedelic" in a broad sense — both produce altered states of consciousness, even though the mechanisms differ.
2. Both promote neuroplasticity — though through different pathways, the downstream effects on synaptic remodeling and BDNF overlap.
3. Both are being studied for similar indications — depression, anxiety, PTSD, end-of-life distress.

The practical answer for most patients: ketamine is the option you can actually access through legitimate medical channels right now. DMT remains research-phase. That's the most important difference if you're trying to decide what to do this year, not what you'd theoretically prefer.

Therapeutic frameworks: similar shape, different timing

Both ketamine-assisted psychotherapy (KAP) and emerging DMT-assisted protocols follow the same three-phase structure:

1. Preparation — assessment, intention-setting, education
2. Dosing session — supervised administration in a therapeutic setting
3. Integration — sessions afterward to translate the experience into behavior change

The difference is that KAP is a well-developed clinical practice with hundreds of providers nationally, while DMT-assisted therapy exists mostly in research and ceremonial contexts. The integration work is what does most of the long-term therapeutic lifting in either modality — the dose alone doesn't change much without it.

For ketamine, supervised at-home protocols handle all three phases through a combination of physician video visits and self-administered sublingual or oral dosing.

Risks and safety considerations

Ketamine

Under supervision: well-tolerated. Common acute effects are transient dissociation, blood pressure elevation, and nausea. Risks scale with frequency and dose — chronic high-frequency recreational use is associated with bladder dysfunction and cognitive effects. Clinical dosing (every 1–4 weeks) keeps cumulative exposure low.

DMT

Low physical toxicity. The intensity of the experience itself is the main risk — particularly for people with personal or family history of psychotic disorders, where psychedelics are generally contraindicated. Ayahuasca interacts dangerously with SSRIs and several other medications via the MAOI component.

Both

Unsupervised use compounds risk. Most adverse events in psychedelic research are from contexts without screening, preparation, or integration support.

Online and at-home ketamine therapy

Because ketamine is legally prescribable, telehealth-mediated at-home ketamine therapy is the most accessible psychedelic-adjacent treatment today. A typical protocol:

• Initial video consultation with a physician for screening
• Personalized dosing plan (usually sublingual troches or oral)
• Self-administered sessions at home with telehealth support
• Integration sessions between doses

DMT therapy doesn't have an equivalent at-home option — the legal status alone makes that impossible in the U.S.

FAQs

What's the main difference between DMT and ketamine?

Ketamine blocks NMDA glutamate receptors and produces a dissociative state for 1–2 hours; DMT activates serotonin 5-HT2A receptors and produces a vivid psychedelic experience lasting 15 minutes to 6 hours depending on the form. Ketamine is legal and prescribed; DMT is Schedule I outside research.

Is ketamine or DMT better for depression?

Ketamine is currently the only one with robust clinical evidence and legal availability for depression treatment. DMT is in earlier-phase research. If you're choosing a treatment you can actually access today, ketamine is the answer.

Are both DMT and ketamine legal for medical use?

Ketamine yes (anesthesia + Spravato for TRD + off-label for psychiatric indications). DMT no — Schedule I in the U.S., available only in clinical trials or limited ceremonial contexts.

Is 5-MeO-DMT the same as DMT?

They're closely related but distinct. N,N-DMT (commonly just called "DMT") produces vivid visual imagery; 5-MeO-DMT typically produces less visual content but more profound ego-dissolution experiences. Both are Schedule I. See 5-MeO-DMT for depression for more.

Can DMT and ketamine be used together?

There is no established clinical protocol for combining them. Some research is exploring sequential or combination use, but co-administration outside research is strongly discouraged.

---

Related Articles

• Psilocybin vs Ketamine: Which Offers Better Healing?
• Ketamine vs Microdosing: Legal Use and Mental Health Therapy
• MDMA-Assisted Psychotherapy: A Promising Step Toward Healing

---

Considering ketamine therapy? Unlike DMT, ketamine is legally available and can be done at home with physician supervision. Isha Health offers physician-led at-home treatment with an 88.8% improvement rate. Check appointment availability.